HENDERSON MOLLY (CFO and CBO) sold 4.2% of their position (4.33K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $50.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/17/2024ACC: 0000950170-24-084182
Officer· CFO and CBO
Since Apr 2022
-4.33K
Net shares
Net seller
$50.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.33K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.33K
Price / share
$11.72
Trade value
$50.69K
% of position
4.2%
7/15/2024
103.77K→99.45K
Total
Net shares
−4.33K
Net value
-$50.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/15/2024 | S · Sale | −4.33K | $11.72 | $50.69K | 4.2% | 103.77K | 99.45K |
| Total | −4.33K | -$50.69K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91K
Total
1.91K indirect1.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91K | Indirect |
| Total | 1.91K | 1.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported